pCMV6-Entry-EPHX1c.416A>G-Flag
(Plasmid
#169170)
-
PurposeExpresses EPHX1 c.416A>G in mammalian cells
-
Depositing Labs
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 169170 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcmv entry
- Backbone size w/o insert (bp) 4900
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameepoxide hydrolase 1
-
Alt nameEPHX1
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1461
-
Mutationc.337T>C
-
GenBank IDNM_000120
-
Entrez GeneEPHX1 (a.k.a. EPHX, EPOX, HYL1, MEH)
- Promoter CMV
-
Tag
/ Fusion Protein
- flag (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site sgfI (not destroyed)
- 3′ cloning site MluI (not destroyed)
- 5′ sequencing primer GGACTTTCCAAAATGTCG (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byOrigene
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCMV6-Entry-EPHX1c.416A>G-Flag was a gift from Bruno Feve & Jeremie Gautheron (Addgene plasmid # 169170 ; http://n2t.net/addgene:169170 ; RRID:Addgene_169170) -
For your References section:
EPHX1 mutations cause a lipoatrophic diabetes syndrome due to impaired epoxide hydrolysis and increased cellular senescence. Gautheron J, Morisseau C, Chung WK, Zammouri J, Auclair M, Baujat G, Capel E, Moulin C, Wang Y, Yang J, Hammock BD, Cerame B, Phan F, Feve B, Vigouroux C, Andreelli F, Jeru I. Elife. 2021 Aug 3;10. pii: 68445. doi: 10.7554/eLife.68445. 10.7554/eLife.68445 PubMed 34342583